Huma, a developer of regulated disease management software, raised $80 million in Series D funding to roll up early-stage digital health players, CEO Dan Vahdat tells Axios.
Why it matters: Digital health companies are the top acquirers of their peers — but many larger players are facing pressure to be conservative on M&A, per a Rock Health report.
